Evidence map›Paper›PMID 39677216›Full record

ArticleCureus2024

A Case of Rapidly Progressive Glomerulonephritis Associated With Metastatic Melanoma.

Sitara Rao, Moeed Ahmed, Abdul R Ahmed, Julia Brown

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sitara RaoDepartment of Medicine, University of Illinois Chicago, Chicago, USA.
Moeed AhmedDepartment of Medicine, Northwestern University, Chicago, USA.
Abdul R AhmedCollege of Medicine, Lahore Medical and Dental College, Lahore, PAK.
Julia BrownDepartment of Medicine, University of Illinois Chicago, Chicago, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pauci-immune glomerulonephritis is a rapidly progressive form of glomerulonephritis. It is distinguished from other rapidly progressive glomerular diseases by the lack of immune deposits seen on renal biopsy, hence the name "pauci-immune." We present a case of pauci-immune glomerulonephritis in a patient with a history of malignancy that was treated with chemotherapy. Notably, the presentation of kidney injury coincided with the discovery of a new metastasis. Prompt treatment of glomerulonephritis is critically important to preserve renal function, though the optimal treatment strategy may not be straightforward in a patient with coexisting malignancy. Ultimately, this case illustrates that collaboration between patients, medical teams, and families is needed to optimize treatment strategy in unique circumstances.

Indexed as

acute kidney injuryimmune checkpoint inhibitor (ici)paraneoplastic syndromepauci-immune glomerulonephritis (gn)renal vasculitis

Identifiers

PMID39677216
PMCPMC11646190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.